Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Cost-effectiveness of Platelet Function-Guided Strategy with Clopidogrel or Ticagrelor
Author(s): Nikita Lomakin , Anna Rudakova , Liudmila Buryachkovskaya , et al Added: 3 years ago
Antiplatelet agents are part of secondary prevention following acute coronary syndrome (ACS). Current European and Russian guidelines recommend dual antiplatelet therapy for 1 year after ACS.1,2 Prasugrel is not marketed in Russia, so high-risk patients have been given ticagrelor. The proportion of generic clopidogrel administered has been steadily rising, with the average cost of treatment… View more

Anticoagulation

MI/ACS
Validated Cost Effectiveness of Medtronic Reveal LINQ
Author(s): Klaus Witte , Matthew Reynolds , Paul Guyler Start date: Oct 13, 2020

Electrophysiology & Arrhythmia
Author(s): Olusola A Orimoloye , Albert D Osei , SM Iftekhar Uddin , et al Added: 3 years ago
It often takes time to accumulate enough evidence to deem causal hypotheses plausible truths. Since the introduction of e-cigarettes about a decade ago, studies assessing their potential health effects have resulted in a weak evidence base for causal links to several important clinical outcomes.1 Specifically, according to the National Academies of Science, Engineering, and Medicine’s summary of… View more

Prevention & Chronic Conditions
Author(s): Tim Leiner , Susanne Kienbaum Added: 3 years ago
Peripheral arterial occlusive disease (PAOD) is a major health risk. The prevalence of PAOD varies with the population observed and the screening method used. In epidemiological studies, measurement of the ankle/brachial index (ABI) is recommended for screening (ABI <0.9 indicates PAOD). Surveys in Germany based on the ABI showed a PAOD prevalence of 2.3% among women aged 45–49 years and of 2… View more

Imaging & Diagnostics
Author(s): Carsten Schwenke , Monica Boos , Rainer Hentrich , et al Added: 3 years ago
Since its introduction in 1993,1 contrast-enhanced magnetic resonance angiography (ce-MRA) has been considered the technique of choice for angiographic examination of most regions of the body. This is because of several technical and clinical advantages in comparison with non-contrast-enhanced MRA (nce-MRA) imaging. In this article, we focus on patients with suspected peripheral arterial… View more

Imaging & Diagnostics
ESC 23: Economic Burden of CVD in the EU
Author(s): Ramón Luengo-Fernández Added: 7 months ago
ESC 2023 — Dr Ramón Luengo-Fernández (University of Oxford, UK) joins us on-site to discuss the findings from a registry which aimed to analyse the economic burden of cardiovascular disease within the EU. This was the first study to utilise Europe-wide patient registries and included the costs of long-term social care. Results from the registry found that cardiovascular disease cost the EU €282… View more

Standards & Guidelines
Foreword

Article

Author(s): Alberico L Catapano Added: 3 years ago
In the last couple of decades we have witnessed the explosion of cardiovascular (CV) therapies. These treatments now account for the majority of the daily prescriptions issued by physicians. The ageing of the population has led to CV diseases becoming major contributors to morbidity and mortality throughout the world. However, in real life we are facing a major issue concerning the patient’s… View more

Prevention & Chronic Conditions
Author(s): Roxy Senior Added: 3 years ago
Stress echocardiography, which was introduced in the early 1980s, has matured to a reliable cost-effective method for diagnosing and risk-stratifying patients with suspected or known coronary artery disease (CAD). The use of stress echocardiography as the non-invasive method of choice for assessment of CAD has increased exponentially worldwide. In the US alone, approximately three million stress… View more

Imaging & Diagnostics
AI powered CT based Non Invasive CAD testing
Author(s): Derek Connolly , , Added: 2 years ago
According to NICE,HeartFlow FFRct should be considered as an option for patients with stable, recent-onset chest pain who are offered CCTA. Using HeartFlow FFRct may avoid the need for invasive coronary angiography and revascularisation. Based on the current evidence and assuming there is access to appropriate CCTA facilities, using HeartFlow FFRct may lead to cost savings of £391 per… View more

Imaging & Diagnostics

Prevention & Chronic Conditions
Author(s): David E Allie , Chris J Herbert , Craig M Walker Added: 3 years ago
Despite the recent introduction of vascular closure device (VCD) technology, vascular access site complications remain the leading source of morbidity and costs after the approximately eight to eight-and-a-half million percutaneous catheter-based procedures performed annually worldwide.1 VCD trials consistently demonstrate increased patient satisfaction, early ambulation, and decreased hospital… View more

Imaging & Diagnostics